National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01EB01	GEFITINIB ARROW	G	Gefitinib - 250mg	250mg	Tablet, coated	L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,104,639 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	581,884 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	568,445 L.L
L01EA01	GLIMATINIB BENTA 400	G	Imatinib (mesylate) - 400mg	400mg	Tablet, film coated	38,254,090 L.L
L01EA01	GLIMATINIB BENTA 400	G	Imatinib (mesylate) - 400mg	400mg	Tablet, film coated	L.L
L01EA01	GLIVEC	B	Imatinib (mesylate) - 100mg	100mg	Tablet, film coated	50,531,993 L.L
J05AR18	GENVOYA	B	Emtricitabine - 200mg, Tenofovir alafenamide - 10mg, Elvitegravir - 150mg, Cobicistat - 150mg		Tablet, film coated	77,789,650 L.L
L01EA01	GLIMATINIB BENTA	G	Imatinib (mesylate) - 100mg	100mg	Tablet, film coated	17,619,185 L.L
L01EA01	GLIMATINIB BENTA	G	Imatinib (mesylate) - 100mg	100mg	Tablet, film coated	43,103,200 L.L
C09CA04	GIZLAN	G	Irbesartan - 150mg	150mg	Tablet, film coated	748,520 L.L
C09CA04	GIZLAN	G	Irbesartan - 300mg	300mg	Tablet, film coated	768,678 L.L
A10BA02	GLUCOPHAGE	B	Metformin HCl - 850mg	850mg	Tablet, film coated	572,634 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	395,090 L.L
A10BA02	GLYSTOR	G	Metformin HCl - 850mg	850mg	Tablet, film coated	454,347 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	395,090 L.L
A10BA02	GLUCOPHAGE	B	Metformin HCl - 1,000mg	1,000mg	Tablet, film coated	624,963 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 25mg		Tablet, film coated	768,678 L.L
A03FA07	GAROPRIDE	G	Itopride Hydrochloride - 50mg	50mg	Tablet, film coated	213,671 L.L
A10BD02	GLUCOVANCE	B	Metformin HCl - 500mg, Glibenclamide - 2.5mg		Tablet, film coated	563,663 L.L
A10BD02	GLUCOVANCE	B	Metformin HCl - 500mg, Glibenclamide - 5mg		Tablet, film coated	775,971 L.L
A10BD02	GLUCOVANCE	B	Metformin HCl - 1000mg, Glibenclamide - 5mg		Tablet, film coated	1,006,220 L.L
A10BD02	GLIBOMET	B	Metformin HCl - 400mg, Glibenclamide - 5mg		Tablet, film coated	462,282 L.L
B01AC04	GREPID	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet, film coated	1,297,770 L.L
A10BD08	GALVUS MET	B	Metformin HCl - 1,000mg, Vildagliptin - 50mg		Tablet, film coated	1,816,875 L.L
A10BD08	GLUNORM M	G	Metformin HCl - 1000mg, Vildagliptin - 50mg		Tablet, film coated	1,089,856 L.L
A10BD08	GALVUS MET	B	Metformin HCl - 850mg, Vildagliptin - 50mg		Tablet, film coated	1,816,875 L.L
A10BD08	GLUNORM M	G	Metformin HCl - 850mg, Vildagliptin - 50mg		Tablet, film coated	1,089,856 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg		Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg		Tablet, film coated	4,482,387 L.L